F. Roila

1.8k total citations · 1 hit paper
22 papers, 1.1k citations indexed

About

F. Roila is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, F. Roila has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 5 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in F. Roila's work include Neutropenia and Cancer Infections (6 papers), Hematological disorders and diagnostics (4 papers) and Nausea and vomiting management (3 papers). F. Roila is often cited by papers focused on Neutropenia and Cancer Infections (6 papers), Hematological disorders and diagnostics (4 papers) and Nausea and vomiting management (3 papers). F. Roila collaborates with scholars based in Italy, United States and United Kingdom. F. Roila's co-authors include Jeffrey Crawford, Claudia Caserta, M.H. Cullen, Francisca M. Marti, M. John Gill, Igor Novitzky‐Basso, Julien de Naurois, Karin Jordan, Joachim Weis and Alessandra Fabi and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Biomedicine & Pharmacotherapy.

In The Last Decade

F. Roila

22 papers receiving 1.1k citations

Hit Papers

Cancer-related fatigue: ESMO Clinical Practice Guidelines... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Roila Italy 12 829 227 182 181 178 22 1.1k
Carmen P. Escalante United States 14 605 0.7× 264 1.2× 70 0.4× 176 1.0× 160 0.9× 25 942
Carmelita P. Escalante United States 10 710 0.9× 309 1.4× 51 0.3× 317 1.8× 73 0.4× 24 1.2k
John Wiernikowski Canada 15 318 0.4× 136 0.6× 36 0.2× 209 1.2× 46 0.3× 28 814
Charles G. Martin United States 17 288 0.3× 127 0.6× 39 0.2× 149 0.8× 55 0.3× 26 974
T. Robin Goodman United States 9 193 0.2× 35 0.2× 106 0.6× 147 0.8× 111 0.6× 13 1.1k
Floor Abbink Netherlands 18 243 0.3× 92 0.4× 34 0.2× 172 1.0× 22 0.1× 37 724
Tracy Wolff United States 15 147 0.2× 119 0.5× 41 0.2× 106 0.6× 15 0.1× 30 1.0k
Ioannis Bellos Greece 22 100 0.1× 267 1.2× 79 0.4× 390 2.2× 35 0.2× 99 1.5k
Tal Schechter Canada 20 282 0.3× 135 0.6× 69 0.4× 561 3.1× 11 0.1× 122 1.4k
Enrique de‐Madaria Spain 27 1.0k 1.3× 512 2.3× 106 0.6× 53 0.3× 15 0.1× 121 2.4k

Countries citing papers authored by F. Roila

Since Specialization
Citations

This map shows the geographic impact of F. Roila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Roila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Roila more than expected).

Fields of papers citing papers by F. Roila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Roila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Roila. The network helps show where F. Roila may publish in the future.

Co-authorship network of co-authors of F. Roila

This figure shows the co-authorship network connecting the top 25 collaborators of F. Roila. A scholar is included among the top collaborators of F. Roila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Roila. F. Roila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Metro, Giulio, Alessio Gili, Diego Signorelli, et al.. (2021). Upfront pembrolizumab as an effective treatment start in patients with PD-L1 ≥ 50% non-oncogene addicted non-small cell lung cancer and asymptomatic brain metastases: an exploratory analysis. Clinical & Translational Oncology. 23(9). 1818–1826. 15 indexed citations
2.
Fabi, Alessandra, Ravi Bhargava, Sonia Fatigoni, et al.. (2020). Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment. Annals of Oncology. 31(6). 713–723. 323 indexed citations breakdown →
3.
Crinò, Lucio, Paolo Bidoli, F. Roila, et al.. (2017). Efficacy and safety data from patients with advanced non-squamous NSCLC and brain metastases from the nivolumab expanded access programme (EAP) in Italy. Annals of Oncology. 28. v469–v469. 4 indexed citations
4.
Grossi, Francesco, Lucio Crinò, Angelo Delmonte, et al.. (2017). Italian nivolumab expanded access programme: real-world results in non-squamous non-small cell lung cancer patients. Annals of Oncology. 28. v410–v411. 2 indexed citations
5.
Roila, F., Francesco Spina, Carla B. Ripamonti, et al.. (2016). Incidence, characteristics and treatment of fatigue in oncological cancer patients (pts) in italy: a cross-section study. Annals of Oncology. 27. iv110–iv110. 2 indexed citations
6.
Crawford, Jeffrey, Claudia Caserta, & F. Roila. (2010). Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications. Annals of Oncology. 21. v248–v251. 165 indexed citations
7.
Naurois, Julien de, Igor Novitzky‐Basso, M. John Gill, et al.. (2010). Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Annals of Oncology. 21. v252–v256. 281 indexed citations
8.
Marti, Francisca M., M.H. Cullen, & F. Roila. (2009). Management of febrile neutropenia: ESMO Clinical Recommendations. Annals of Oncology. 20. iv166–iv169. 25 indexed citations
9.
Crawford, Jeffrey, Claudia Caserta, & F. Roila. (2009). Hematopoietic growth factors: ESMO Recommendations for the applications. Annals of Oncology. 20. iv162–iv165. 36 indexed citations
10.
Langhorst, Jost & F. Roila. (2009). Management of cancer pain: ESMO Clinical Recommendations. Annals of Oncology. 20. iv170–iv173. 38 indexed citations
11.
Greil, Richard, et al.. (2008). Erythropoietins in cancer patients: ESMO Recommendations for use. Annals of Oncology. 19. ii113–ii115. 9 indexed citations
12.
Roila, F., Enzo Ballatori, L. Patoia, et al.. (2003). Adjuvant systemic therapies in women with breast cancer:an audit of clinical practice in Italy. Annals of Oncology. 14(6). 843–848. 26 indexed citations
13.
Ruggeri, Benedetta, Enzo Ballatori, Paolo G. Casali, et al.. (1999). Awareness of disease: a cross-sectional study on Italian cancer patients. European Journal of Cancer. 35. S276–S276. 1 indexed citations
14.
Ballatori, Enzo, F. Roila, Valerio De Angelis, et al.. (1997). Clinical and methodological issues in antiemetic therapy: a worldwide survey of experts' opinions. Supportive Care in Cancer. 5(4). 269–273. 7 indexed citations
15.
Tonato, Maurizio, F. Roila, & A. Del Favero. (1994). Are there differences among the serotonin antagonists?. Supportive Care in Cancer. 2(5). 293–296. 5 indexed citations
16.
Roila, F., Marco Lupattelli, M. Sassi, et al.. (1991). Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales. Annals of Oncology. 2(6). 437–439. 96 indexed citations
17.
Roila, F., Maurizio Tonato, C. Basurto, et al.. (1990). A pilot study of metoclopramide, dexamethasone, diphenhydramine and acupuncture in women treated with cisplatin. Cancer Chemotherapy and Pharmacology. 26(3). 239–240. 30 indexed citations
18.
Roila, F.. (1989). Buserelin in the treatment of prostatic cancer. Biomedicine & Pharmacotherapy. 43(4). 279–285. 4 indexed citations
19.
Menichetti, Francesco, A. Del Favero, Roberto Guerciolini, et al.. (1987). Viridans streptococci septicemia in cancer patients: A clinical study. European Journal of Epidemiology. 3(3). 316–318. 21 indexed citations
20.
Menichetti, Francesco, A. Del Favero, Roberto Guerciolini, et al.. (1986). Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazole. Infection. 14(6). 261–267. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026